Eyewire News: The Podcast
105 episodes — Page 1 of 3
EyePoint Misses Primary Endpoint in Phase 3 Trial But Sees Promise After Analysis
Aug 26, 20265 min
Three Major Acquisitions Announced in Ophthalmology
Aug 12, 20265 min
Biocon Launches Eylea Biosimilar Yesafili
Aug 5, 20264 min
FDA Approves Outlook's Lytenava for Wet AMD
Jul 29, 202611 min
PRIMA Retinal Implant Launched in EU
Jul 22, 20265 min
Tarsus Buys Investigational Ocular Antiseptic
Jul 15, 20265 min
Viridian Executive Discusses FDA Approval of New TED Therapy
Jul 1, 202614 min
Ocular Updates Plans for Axpaxli NDA for Wet AMD
Jun 24, 20266 min
Tecnis PureSee IOL Fully Launched in the US
Jun 17, 20266 min
Study Examines Semaglutide and Wet AMD Risk
Jun 10, 20264 min
Oculis Announces Phase 3 Results for DME Eye Drops
Jun 3, 20264 min
Outlook Wins Appeal for Wet AMD Drug Candidate Lytenava
May 27, 20264 min
Next-Generation FSYX Goggles Approved for Glaucoma
May 20, 20268 min
Future of Posterior Therapeutics
May 13, 202610 min
Bayer Acquires Perfuse in $2.45 Billion Deal
May 6, 20266 min
How Ophthalmology Strategics are Rewriting the Playbook
Apr 29, 20266 min
Glaukos Issued J-Code for Recently Launched Epioxa
Apr 22, 20265 min
Breaking News from the ASCRS Meeting in Washington DC
Apr 15, 202613 min
More than 3 Million Bottles of Eye Drops Recalled
Apr 8, 20264 min
Biogen Enters GA Treatment Market After Major Acquisition
Apr 1, 20265 min
Interview with ASCRS Executive Director Steve Speares
Mar 25, 202611 min
Alcon and Lensar Call Off Merger
Mar 18, 20266 min
FDA Agrees to Review Phentolamine for Presbyopia
Mar 4, 202611 min
Zeiss Launches App to Improve Workflow
Feb 25, 20263 min
Ocular Releases Phase 3 Data for Wet AMD Candidate Axpaxli
Feb 18, 20266 min
Study: Metformin May Lower AMD Progression
Feb 11, 20265 min
First Dual-Agent Eye Drop for Presbyopia Approved
Feb 4, 20267 min
FDA Approves Label Supplement for iDose TR
Jan 28, 20265 min
Rayner Launches New Phaco System
Jan 21, 20264 min
Moorfields Researchers Reveal Promising Treatment for Hypotony
Jan 14, 202610 min
Staar Terminates Merger with Alcon
Jan 7, 202611 min
2025 Year in Review - Part 2
Dec 31, 20258 min
2025 Year in Review - Part 1
Dec 24, 20259 min
Update on Reproxalap PDUFA Timing
Dec 17, 20258 min
New Glaucoma Technologies Advance in Clinical Development
Dec 10, 20255 min
Eylea HD Approved for RVO and Extended Dosing
Dec 3, 20255 min
Leaders Discuss Emerging Technologies in Glaucoma
Nov 26, 202513 min
Live Coverage of B+L Investor Day
Nov 18, 20256 min
Ryjunea Approved in the UK for Myopia
Nov 12, 20255 min
Ophthalmic Executives Provide Company Updates (Part 2 of 2)
Nov 5, 202515 min
Ophthalmic Executives Provide Company Updates (Part 1 of 2)
Oct 29, 202516 min
Breaking News from the AAO Meeting in Orlando
Oct 22, 202521 min
First Robotic Cataract Surgery Performed
Oct 15, 20257 min
Lenz Therapeutics' Vizz Commerically Launched
Oct 8, 20256 min
Visionary Breakthroughs: A Spotlight on Innovations in Eye Care (Part 2 of 2)
Oct 1, 202517 min
Visionary Breakthroughs: A Spotlight on Innovations in Eye Care (Part 1 of 2)
Sep 24, 202518 min
Breaking News From the ESCRS Congress in Copenhagen
Sep 17, 202516 min
Vision Advocacy Leaders Speak Out Against Proposed NEI Cuts
Sep 10, 202515 min
Update on Investigational Treatments for Retinal Diseases
Sep 3, 20257 min
CE Certification for New Glaucoma Surgical Implant
Aug 27, 20254 min